Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1995 1
1996 3
2000 1
2001 3
2002 3
2003 1
2004 2
2005 2
2006 2
2007 1
2008 1
2009 1
2010 2
2011 1
2012 1
2014 5
2015 4
2017 2
2019 1
2020 3
2021 2
2022 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac toxicity of high-dose chemotherapy.
Morandi P, Ruffini PA, Benvenuto GM, Raimondi R, Fosser V. Morandi P, et al. Among authors: ruffini pa. Bone Marrow Transplant. 2005 Feb;35(4):323-34. doi: 10.1038/sj.bmt.1704763. Bone Marrow Transplant. 2005. PMID: 15543194 Review.
Recent advances in multiple myeloma immunotherapy.
Ruffini PA, Biragyn A, Kwak LW. Ruffini PA, et al. Biomed Pharmacother. 2002 May;56(3):129-32. doi: 10.1016/s0753-3322(02)00169-5. Biomed Pharmacother. 2002. PMID: 12046683 Review.
Armed antibodies for cancer treatment: a promising tool in a changing era.
Danielli R, Patuzzo R, Ruffini PA, Maurichi A, Giovannoni L, Elia G, Neri D, Santinami M. Danielli R, et al. Among authors: ruffini pa. Cancer Immunol Immunother. 2015 Jan;64(1):113-21. doi: 10.1007/s00262-014-1621-0. Epub 2014 Oct 15. Cancer Immunol Immunother. 2015. PMID: 25314912 Review.
CXCR1/2 pathways in paclitaxel-induced neuropathic pain.
Brandolini L, Benedetti E, Ruffini PA, Russo R, Cristiano L, Antonosante A, d'Angelo M, Castelli V, Giordano A, Allegretti M, Cimini A. Brandolini L, et al. Among authors: ruffini pa. Oncotarget. 2017 Apr 4;8(14):23188-23201. doi: 10.18632/oncotarget.15533. Oncotarget. 2017. PMID: 28423567 Free PMC article.
Immunotherapy of multiple myeloma.
Ruffini PA, Kwak LW. Ruffini PA, et al. Semin Hematol. 2001 Jul;38(3):260-7. doi: 10.1016/s0037-1963(01)90018-6. Semin Hematol. 2001. PMID: 11486314 Review.
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida).
Goldstein LJ, Mansutti M, Levy C, Chang JC, Henry S, Fernandez-Perez I, Prausovà J, Staroslawska E, Viale G, Butler B, McCanna S, Ruffini PA, Wicha MS, Schott AF; fRida Trial Investigators. Goldstein LJ, et al. Among authors: ruffini pa. Breast Cancer Res Treat. 2021 Nov;190(2):265-275. doi: 10.1007/s10549-021-06367-5. Epub 2021 Sep 3. Breast Cancer Res Treat. 2021. PMID: 34476645 Free PMC article. Clinical Trial.
43 results